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1. Introduction
Massive hemoptysis is defined as the life-threatening bleeding
threshold of 100–1000mL in a 24-h period or an amount greater than
8mL/kg every 24 h. Although there is no accepted definition, a diag-
nosis of massive hemoptysis is made when it results in respiratory and
hemodynamic compromise [1]. It is a rare occurrence in childhood with
various known etiologies. Common diagnoses in pediatric patients in-
clude infection, foreign body aspiration, trauma, tracheostomy-related
issues, or cystic fibrosis. The most common cause of hemoptysis in-
volves infectious processes, which may include pneumonia, tubercu-
losis, and parasitic or fungal infections [2–4]. A retrospective review
conducted by Simon et al. reported that 40% of pediatric hemoptysis
cases identified infectious processes as the most common cause [5]. A
separate retrospective review found that infection was the main cau-
sative factor amongst pediatric cases, and, more specifically, congenital
heart disease and infection were the leading causes in the adolescent
population [6]. (see Figs. 1 and 2)
Frequently utilized diagnostic modalities for hemoptysis include
chest radiograph, computed tomography, culture studies, and
bronchoscopy. A review conducted at Children's Memorial Hospital in
Chicago found that the diagnostic yield for chest radiography was 53%
for this patient sample [1]. Approximately one third of pediatric pa-
tients with hemoptysis are known to have normal chest radiographs
[6]. While chest X-ray is the first line of investigation in patients with
hemoptysis, further investigation with CT and bronchoscopy may be
necessary if no lesion is identified [7]. The review from Children's
Memorial Hospital also stated that when utilizing bronchoscopy to di-
agnose the cause of hemoptysis, the correct etiology was determined in
61% of patients [2].
Initial management of massive hemoptysis consists of respiratory
and circulatory support with mechanical intubation and replacement of
fluids and/or blood products. Bronchoscopy and bronchial artery em-
bolization and some measures to control bleeding that does not respond
to conservative measures. Surgery with lung resection is a last resort.
ECMO to provide respiratory and hemodynamic support has been very
rarely utilized in these patients (and probably under-utilized). We
present a case where a combination of emergent surgery and initiation
of ECMO were required to stabilize a patient with massive hemoptysis.
2. Case report
The patient is a 15-year-old, 100 kg male, with a past medical his-
tory of atrial septal defect, ventricular septal defect and pulmonary
artery valve atresia repair shortly after birth. On the day of admission,
his parents reported he began choking on some ice and experienced
sudden massive hemoptysis. He was intubated at an outside institution
but had bleeding out of the ETT. Upsizing of ETT was unsuccessful and
so was an attempted tracheostomy. He was successfully orotracheally
intubated prior to transfer after a significant hypoxic time.
Upon transfer to our institution, the patient was started on an epi-
nephrine drip and stabilized on the ventilator. A CBC revealed a WBC of
28.5 k/cumm, hemoglobin 10.6 GM/dL and platelets 232 k/cumm,
while a chest x-ray demonstrated scattered patchy airspace opacities
with left apical and right basilar predominance compatible with in-
fection or edema. Approximately 17–19mmHg of PEEP was required to
tamponade bleeding, and he required peak inspiratory pressures more
than 40mm Hg to maintain adequate tidal volumes. Once he was
clinically stable on the second hospital day, a CT angiography of the
chest was performed, demonstrating complete obstruction of the
bronchus intermedius with atelectasis of the posterior basal segment of
the right lower lobe. It was also suggestive of a foreign body in the right
lower lobe. No contrast blush consistent with bleeding was noted.
Initially, embolization of bleeding vessels was considered, however it
was felt to likely be unsuccessful given the concern on CT for a foreign
body and no active hemorrhage at that time.
On day 3 of admission he went to the OR for a thoracotomy with
planned lobectomy to control the bleeding airways. During that pro-
cedure, he required emergent partial right middle and lower lobec-
tomies due to severe hypoxia secondary to sudden and severe hemor-
rhage through the ETT. The right lower and middle lobes were taken
emergently with a TIA stapler in a damage control fashion. An ECMO
circuit was kept on standby from the outset of the operation, and when
the patient developed persistent hypoxia, the decision was made to
cannulate for ECMO. After the thoracotomy was quickly closed with a
temporary dressing, ECMO was initiated by inserting a 28Fr double
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Fig. 1. CT virtual bronchoscopy showing obstruction of right middle lobe and lower bronchi.
Fig. 2. CT chest showing calcified granuloma in the right lung.
D. Nunez, et al. Journal of Pediatric Surgery Case Reports 48 (2019) 101260
2
lumen OriGen (OriGen Biomedical, Austin, TX) cannula in the right
internal jugular vein and a 23Fr single lumen cannula in the right fe-
moral vein (VV–V ECMO). These sizes were based on our reference
cannulation size charts. Both cannulas were placed percutaneously
using ultrasound guidance. The patient experienced cardiac arrest just
before ECMO was started but regained spontaneous circulation while
the ECMO flow was slowly increased. After the patient was stabilized, a
bronchoscopy was performed where blood clots including “granuloma”-
like material were cleared from the airways.
He remained on ECMO for 5 days. He was maintained on an in-
stitutional high risk bleeding protocol with low heparin doses and goal
anti-Xa levels of 0.3–0.7 IU/mL. Good flows were maintained on ECMO
(4.3–4.5 L/min) with a target peripheral oxygen saturation of 85–88%.
The patient was maintained on APRV ventilation during his time on
ECMO. ECMO was eventually discontinued on post-operative day
(POD) 4. During his time on ECMO he required redo chest explorations
and washouts with control of bleeding at the bedside on 3 separate
occasions. Pulmonology was consulted on POD 2, and a bedside
bronchoscopy revealed clots in the left mainstem bronchus, which were
suction cleared. The right mainstem was also filled with clots without
active bleeding, but these clots were not able to be cleared.
After discontinuing chemical paralysis and ECMO decannulation,
the patient had a smaller volume episode of hemoptysis. A flexible
bronchoscopy showed a clot in the right mainstem bronchus. A repeat
CT chest showed the areas of potential bleeding were the remnant
middle and lower lobes. This led to a return to the operating room for
completion of the right middle and lower lobectomies. This operation
proceeded without complications. Pathology of the lung samples
showed massive multiple necrotizing granulomas with microorganisms
whose morphology was most consistent with Histoplasma capsulatum.
Acid fast bacilli stains were negative. The patient was started on am-
photericin B on day 6 of his hospitalization and was switched over to
itraconazole on day 11. However, pathology was more consistent with
an old infection (due to calcified granulomas), and urinary and blood
serology were negative for histoplasmosis. Also, the lesions were
completely resected. Antifungals were thus stopped on day 13 of hos-
pitalization.
Our patient improved from the respiratory standpoint and was tol-
erating CPAP trials in 2 weeks. He was extubated on the fourth week of
his hospital stay. His neurological exam remained unchanged during
this course, as the patient did not initially respond to pain or commands
and continued to have purposeless movements. An EEG demonstrated
severe encephalopathy with areas that could precipitate focal and
secondary generalized seizures. He was discharged to inpatient re-
habilitation. He slowly convalesced and, by the time of discharge, was
awake and participating in therapy.
3. Discussion
Histoplasma capsulatum is a fungus present in soil, caves, and older
buildings and is endemic in the Ohio River Valley. Although often
asymptomatic, it may present with flu-like symptoms, making it diffi-
cult to diagnose. Histoplasmosis-specific IgG antibodies may stay ele-
vated for months or years after infection. There are few recorded in-
cidences of sudden massive hemoptysis secondary to histoplasmosis.
Sheikh et al. described a case of an 11-year-old boy who presented with
moderate hemoptysis and a 2-week history of upper airway congestion
without fever. A chest CT revealed small, calcified nodules with in-
filtrates involving the right upper and lower lobes. Additionally, a rigid
bronchoscopy revealed normal upper airways but bleeding was noted in
the right upper and lower lobes. Bronchoalveolar lavage resulted in
negative cultures for bacteria and negative stains for fungal infection.
After a selective right bronchial artery embolization using gelfoam
slurry the patient had no more hemoptysis and was discharged. Of note,
the authors suspected histoplasmosis as a causative agent for the he-
moptysis due to the CT scan results, which could indicate that the
patient may have lost his antibody titers over time [8].
Shafer et al. reported a case of a 7-year-old boy who presented with
recurrent hemoptysis. Initially, his chest radiograph, physical ex-
amination, and CBC appeared normal. On the 5th day a chest radio-
graph was again performed and showed a patchy right middle and right
lower lobe infiltrate. His course of treatment included a bronchoscopy
to localize the bleeding followed by an emergent right lower lobectomy.
Pathologic diagnosis of the specimen was most consistent with
Histoplasma capsulatum [9].
Histoplasma granuloma induced massive hemoptysis and hypox-
emia is an exceedingly rare indication for ECMO [10]. Utilizing ECMO
in patients with infections such as fungemia or bacteremia is generally
contraindicated due to concerns for circuit contamination. Our patient
had not been found to have Histoplasma capsulatum at the time of
cannulation, and there was no evidence that he had fungemia from
surveillance blood cultures. Also, there was no evidence of active in-
fection in the lungs.
There have been several case reports of patients of all ages being
treated with ECMO as a rescue therapy for respiratory compromise
resulting from massive hemoptysis. Total respiratory bypass allows
clamping of the endotracheal tube with subsequent tamponade of
bleeding, thus potentially avoiding emergent surgical therapy in these
patients. The use of ECMO can also permit better pulmonary toilet to
clear the obstructing debris and clots, providing full support without
the worry of hypoxia from breaking into the ventilator circuit [11–17].
Fortunately, the use of anticoagulants with ECMO has not been shown
to worsen patient outcomes in these cases. However, if possible, lim-
iting or holding anticoagulation altogether is recommended. The use of
anticoagulation in such patients remains a special concern as clinicians
have to balance clotting of circuit with worsening of pulmonary he-
morrhage. Low dose heparin with strict control of ACT, Anti Xa, and
antithrombin III levels, along with liberal use of platelets and FFP is our
preferred method to attain this balance. We also employ the anti-
fibrinolytic agents aminocaproic acid and tranexamic acid situationally
to limit bleeding in high risk patients. Additionally, nafamostat mesy-
late has been used for regional circuit anticoagulation in bleeding pa-
tients due to its short half life, but is not currently approved by the FDA
[15].
In conclusion, we were able to provide full respiratory support to
allow for tamponade of the bleeding airways, gradual airway clearance,
and gentle alveolar recruitment in a patient with massive hemoptysis
due to pulmonary histoplasma infection. This was accomplished by a
well-trained multidisciplinary team emergently initiating VV-ECMO in
a controlled setting. Thus, VV-ECMO should continue to be considered
as an adjunct for emergency airway management. The rare requirement
for emergent surgery for hemoptysis along with resuscitatory measures
involving ECMO make our case unique in literature.
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